Biomarker analysis from completely resected NSCLC patients enrolled in an adjuvant erlotinib clinical trial (RADIANT)

被引：0
|
作者：
Richardson, F.
Richardson, K.
Sennello, G.
Young, D.
Orlov, S.
Papai-Szekely, Z.
Keshavjee, S.
Kim, J.
Cerfolio, R.
Shepherd, F. A.
机构：
[1] OSI Pharmaceut, Boulder, CO USA
[2] St Petersburg State Med Univ, St Petersburg, Russia
[3] Fejer Megyei Szent Gyorgy Korhaz, Szekesfehervar, Hungary
[4] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[5] Yonsei Univ, Severance Hosp, Coll Med, Seoul 120749, South Korea
[6] Univ Alabama Birmingham, Birmingham, AL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7520
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Biomarker analysis from completely resected NSCLC patients enrolled in an adjuvant erlotinib (Tarceva®) clinical trial (RADIANT)
    Richardson, Frank
    Richardson, Katherine
    Sennello, Regina
    Young, David
    Choporov, Sergey
    Gorbunova, Vera
    Heo, Dae-Seog
    Milanowski, Janusz
    Tsai, Chun Ming
    Altorki, Nasser
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S332 - S333
  • [2] SELECT BIOMARKER ANALYSES OF COMPLETELY RESECTED NSCLC TUMORS FROM ENROLLED PATIENTS IN AN ADJUVANT ERLOTINIB (TARCEVA®) CLINICAL TRIAL (RADIANT)
    Richardson, Frank
    Richardson, Katherine
    Young, David
    Sennello, Regina
    Horan, Julie
    Davies, Angela
    Crino, Lucio
    Krzakowski, Maciej
    Hoffman, Philip
    Chang, Gee Chen
    O'Orian, Mary
    Kim, Hoon-Kyo
    Cho, Eun Kyung
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S397 - S398
  • [3] Update on adjuvant therapy in completely resected NSCLC patients
    Lim, Jeong Uk
    Yeo, Chang Dong
    THORACIC CANCER, 2022, 13 (03) : 277 - 283
  • [4] Long-Term Results of Adjuvant Chemotherapy in Completely Resected NSCLC Patients
    Wurstbauer, Karl
    Sedlmayer, Felix
    STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 (07) : 404 - 405
  • [5] A Retrospective Analysis of Adjuvant Chemotherapy in Patients with Completely Resected SCLC
    Tamura, Yosuke
    Fujisaka, Yasuhito
    Nakamura, Takahito
    Tsuji, Hiroyuki
    Matsunaga, Ninso
    Kawaguchi, Tetsufumi
    Imanishi, Masashi
    Yoshida, Syuhei
    Miyoshi, Keiji
    Ikeda, Soichiro
    Goto, Isao
    Hanafusa, Toshiaki
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S744 - S744
  • [6] Canakinumab as Adjuvant Therapy in Patients with Completely Resected Non-Small Cell Lung Cancer (NSCLC): CANOPY-A Trial
    Spira, A. I.
    Ardizzoni, A.
    Barlesi, F.
    Cho, B. C.
    De Marchi, P.
    Goto, Y.
    Kowalski, D.
    Lu, S.
    Paz-Ares, L.
    Spigel, D. R.
    Thomas, M.
    Leung, M.
    Baum, J.
    Zhou, W.
    Portella, S.
    Yang, J. Chih-Hsin
    Garon, E. B.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S25 - S25
  • [7] Biomarker analysis from TRUST, a trial of erlotinib in non-small cell lung cancer (NSCLC)
    Schneider, C.
    Roemer, K. Schott-von
    Guetz, S.
    Raack, B.
    Dierkesmann, R.
    Laack, E.
    Guschall, W.
    Schmittel, A.
    Gatzemeier, U.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] Influence of adjuvant chemotherapy on survival for patients with completely resected high-risk stage IB NSCLC
    Shen, Zi-Qing
    Feng, Kun-Peng
    Fang, Zi-Yao
    Xia, Tian
    Pan, Shu
    Ding, Cheng
    Xu, Chun
    Ju, Sheng
    Chen, Jun
    Li, Chang
    Zhao, Jun
    JOURNAL OF CARDIOTHORACIC SURGERY, 2024, 19 (01)
  • [9] Influence of adjuvant chemotherapy on survival for patients with completely resected high-risk stage IB NSCLC
    Zi-Qing Shen
    Kun-Peng Feng
    Zi-Yao Fang
    Tian Xia
    Shu Pan
    Cheng Ding
    Chun Xu
    Sheng Ju
    Jun Chen
    Chang Li
    Jun Zhao
    Journal of Cardiothoracic Surgery, 19
  • [10] Adjuvant Erlotinib (E) Versus Placebo (P) for Completely Resected Stage IB-IIIA EGFR-Positive (IHC/FISH) Non-Small Cell Lung Cancer (NSCLC): RADIANT Results
    Altorki, N. K.
    O'brien, M. E. R.
    Eberhardt, W. E. E.
    Richardson, F. C.
    Wang, J.
    Foley, M. A.
    Horan, J. D.
    Shepherd, F. A.
    Kelly, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S2 - S3
12345